Tarsus Pharmaceuticals Inc (NASDAQ: TARS) is 16.59% higher on its value in year-to-date trading and has touched a low of $12.57 and a high of $42.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TARS stock was last observed hovering at around $22.69 in the last trading session, with the day’s gains setting it 0.92%.
Currently trading at $23.61, the stock is -9.05% and -16.71% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.8 million and changing 4.05% at the moment leaves the stock -13.53% off its SMA200. TARS registered 39.46% gain for a year compared to 6-month loss of -20.56%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -16.28% gain in the last 1 month and extending the period to 3 months gives it a -36.79%, and is 0.77% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.97% over the week and 7.12% over the month.
Tarsus Pharmaceuticals Inc (TARS) has around 244 employees, a market worth around $891.99M and $42.56M in sales. Profit margin for the company is -348.22%. Distance from 52-week low is 87.83% and -44.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-48.57%).
The EPS is expected to grow by 21.14% this year
The shares outstanding are 34.21M, and float is at 31.03M with Short Float at 28.38%.
Tarsus Pharmaceuticals Inc (TARS) Insider Activity
The most recent transaction is an insider sale by Farrow Jeffrey S, the company’s. SEC filings show that Farrow Jeffrey S sold 10,445 shares of the company’s common stock on Jun 18 ’24 at a price of $27.47 per share for a total of $0.29 million. Following the sale, the insider now owns 18136.0 shares.
Tarsus Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 18 ’24 that Azamian Bobak R. (President/CEO and Board Chair) sold a total of 10,415 shares of the company’s common stock. The trade occurred on Mar 18 ’24 and was made at $30.60 per share for $0.32 million. Following the transaction, the insider now directly holds 26456.0 shares of the TARS stock.
Still, SEC filings show that on Mar 18 ’24, Neervannan Seshadri (Chief Operating Officer) disposed off 4,879 shares at an average price of $30.60 for $0.15 million. The insider now directly holds 64,767 shares of Tarsus Pharmaceuticals Inc (TARS).
